Skip to main content
SpringerLink
Log in

Cohort Studies

  • Chapter
  • First Online:
Epidemiology and Biostatistics

  • 9880 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dooley AC, Weiss NS, Kestenbaum B. Increased risk of hip fracture among men with CKD. Am J Kidney Dis. Jan 2008;51(1):38–44.

    Article  CAS  PubMed  Google Scholar 

  2. Smith NL, Psaty BM, Heckbert SR, Tracy RP, Cornell ES. The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. J Clin Epidemiol. Feb 1999;52(2):143–146.

    Article  CAS  PubMed  Google Scholar 

  3. Belanger CF, Hennekens CH, Rosner B, Speizer FE. The nurses’ health study. Am J Nurs. Jun 1978;78(6):1039–1040.

    Article  CAS  PubMed  Google Scholar 

  4. Avorn J. In defense of pharmacoepidemiology – embracing the yin and yang of drug research. N Engl J Med. Nov 29 2007;357(22):2219–2221.

    Article  CAS  PubMed  Google Scholar 

  5. Aronoff S, Rosenblatt S, Braithwaite S, Egan JW, Mathisen AL, Schneider RL. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. Diabetes Care. Nov 2000;23(11):1605–1611.

    Article  CAS  PubMed  Google Scholar 

  6. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. Jun 14 2007;356(24):2457–2471.

    Article  CAS  PubMed  Google Scholar 

  7. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. Aug 7 2003;349(6):523–534.

    Article  CAS  PubMed  Google Scholar 

  8. Prentice RL, Langer R, Stefanick ML, et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women’s Health Initiative clinical trial. Am J Epidemiol. Sep 1 2005;162(5):404–414.

    Article  PubMed  Google Scholar 

  9. Michaelsson K, Lithell H, Vessby B, Melhus H. Serum retinol levels and the risk of fracture. N Engl J Med. Jan 23 2003;348(4):287–294.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Washington, Seattle, WA, USA

    Bryan Kestenbaum

Authors
  1. Bryan Kestenbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bryan Kestenbaum .

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Kestenbaum, B. (2009). Cohort Studies. In: Epidemiology and Biostatistics. Springer, New York, NY. https://doi.org/10.1007/978-0-387-88433-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-88433-2_5

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-88432-5

  • Online ISBN: 978-0-387-88433-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation